← Leaderboards
Miriam L Greenberg
Wayne State University
$11,653,320
Attributed
$12,820,842
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,820,842 · 12
By mechanism
R01$10,998,298 · 7
R35$1,278,145 · 1
R21$413,875 · 1
R13$74,325 · 2
R25$56,199 · 1
Top collaborators
- Valerian E Kagan3 shared
- Hulya Bayir2 shared
Others in their field
Top investigators on “Yeasts”
- Ronald Wayne Davis · Stanford University$59,405,645
- Jef D Boeke · Brown University$57,512,612
- Joe Michael Cherry · Stanford University$41,914,017
- Alexander D Johnson · University Of California San Francisco$33,901,779
- Nancy E. Kleckner · Harvard University$32,328,905
- Trisha N. Davis · University Of Washington$30,771,014
Research focus
YeastsMyopathyCellsCardiolipinsMitochondrial MembraneMutantPathologyGenesEnzymesPathway InteractionsMolecularHomeostasisMetabolicPlayLinkLipids3-Methylglutaconic Aciduria Type 2Cell PhysiologyAffectProteinsPublic Health RelevanceMitochondriaRegulationGenetic Transcription
Grant awards (48)
Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome$697,006
R01 · FY2025 · HL
Regulation of inositol biosynthesis and consequences of inositol depletion$371,106
R35 · FY2025 · GM · contact PI
2025 Molecular and Cellular Biology of Lipids Gordon Research Conference and Gordon Research Seminar$34,325
R13 · FY2025 · HL · contact PI
Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome$733,848
R01 · FY2024 · HL
Regulation of inositol biosynthesis and consequences of inositol depletion$371,627
R35 · FY2024 · GM · contact PI
Regulation of Inositol Biosynthesis and Consequences of Inositol Depletion$63,283
R35 · FY2024 · GM · contact PI
2024 Scientific and Medical Conference on Barth Syndrome: Benchtop to Treatments$40,000
R13 · FY2024 · HL · contact PI
Regulation of inositol biosynthesis and consequences of inositol depletion$472,129
R35 · FY2023 · GM · contact PI
THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME$371,497
R01 · FY2023 · HL · contact PI
THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME$372,017
R01 · FY2022 · HL · contact PI
Controlling monolysocardiolipin/cytochrome c peroxidase complexes in Barth syndrome$414,409
R01 · FY2021 · GM · contact PI
THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME$372,516
R01 · FY2021 · HL · contact PI
Controlling monolysocardiolipin/cytochrome c peroxidase complexes in Barth syndrome$427,238
R01 · FY2020 · GM · contact PI
THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME$372,996
R01 · FY2020 · HL · contact PI
Novel Mechanisms of Regulation of Inositol Biosynthesis$333,874
R01 · FY2020 · GM · contact PI
Novel Mechanisms of Regulation of Inositol Biosynthesis$128,000
R01 · FY2020 · GM · contact PI
Novel Mechanisms of Regulation of Inositol Biosynthesis$334,207
R01 · FY2019 · GM · contact PI
Novel Mechanisms of Regulation of Inositol Biosynthesis$334,372
R01 · FY2018 · GM · contact PI
Novel Mechanisms of Regulation of Inositol Biosynthesis$51,423
R01 · FY2018 · GM · contact PI
The Role of Cardiolipin In The TCA Cycle: Implications For Barth Syndrome$356,496
R01 · FY2017 · HL · contact PI
Novel Mechanisms of Regulation of Inositol Biosynthesis$334,534
R01 · FY2017 · GM · contact PI
The Role of Cardiolipin In The TCA Cycle: Implications For Barth Syndrome$409,043
R01 · FY2016 · HL · contact PI
The Role of Cardiolipin In The TCA Cycle: Implications For Barth Syndrome$395,280
R01 · FY2015 · HL · contact PI
The Role of Cardiolipin In The TCA Cycle: Implications For Barth Syndrome$16,027
R01 · FY2015 · HL · contact PI
The Role of Cardiolipin In The TCA Cycle: Implications For Barth Syndrome$360,814
R01 · FY2014 · HL · contact PI
A NOVEL MECHANISM OF REGULATION OF INOSITOL BIOSYNTHESIS IN YEAST$319,440
R01 · FY2012 · DK · contact PI
A NOVEL MECHANISM OF REGULATION OF INOSITOL BIOSYNTHESIS IN YEAST$319,573
R01 · FY2011 · DK · contact PI
A NOVEL MECHANISM OF REGULATION OF INOSITOL BIOSYNTHESIS IN YEAST$356,339
R01 · FY2010 · DK · contact PI
A NOVEL MECHANISM OF REGULATION OF INOSITOL BIOSYNTHESIS IN YEAST$100,000
R01 · FY2010 · DK · contact PI
A NOVEL MECHANISM OF REGULATION OF INOSITOL BIOSYNTHESIS IN YEAST$360,080
R01 · FY2009 · DK · contact PI
SYNTHETIC LETHAL INTERACTIONS IN BARTH SYNDROME$188,125
R21 · FY2009 · HL · contact PI
SYNTHETIC LETHAL INTERACTIONS IN BARTH SYNDROME$225,750
R21 · FY2008 · HL · contact PI
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$294,993
R01 · FY2004 · HL
MOLECULAR TARGETS OF LITHIUM AND VALPROATE$218,623
R01 · FY2004 · MH
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$37,768
R01 · FY2004 · HL
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$358,809
R01 · FY2003 · HL
MOLECULAR TARGETS OF LITHIUM AND VALPROATE$218,623
R01 · FY2003 · MH
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$348,792
R01 · FY2002 · HL
MOLECULAR TARGETS OF LITHIUM AND VALPROATE$255,873
R01 · FY2002 · MH
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$74,555
R01 · FY2002 · HL
GENETIC REGULATION OF MITOCHONDRIAL MEMBRANE BIOGENESIS$0
R25 · FY2002 · GM
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$339,068
R01 · FY2001 · HL
MOLECULAR TARGETS OF LITHIUM AND VALPROATE$255,873
R01 · FY2001 · MH
GENETIC REGULATION OF MITOCHONDRIAL MEMBRANE BIOGENESIS$0
R25 · FY2001 · GM
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$274,304
R01 · FY2000 · HL
GENETIC REGULATION OF MITOCHONDRIAL MEMBRANE BIOGENESIS$56,199
R25 · FY2000 · GM
CARDIOLIPIN BIOSYNTHESIS AND FUNCTION$49,988
R01 · FY2000 · HL
GENETIC REGULATION OF MITOCHONDRIAL MEMBRANE BIOGENESIS$0
R25 · FY2000 · GM